|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02500 VENUS MEDTECH-B
Nominal 
4.830 -0.050 (-1.025%) | 2023/06 - Interim RMB(¥) | %Chg (Interim to Interim) | 2022/12 RMB(¥) | 2021/12 RMB(¥) | 2020/12 RMB(¥) | 2019/12 RMB(¥) | ||
| Turnover | 255,610,000 | 21.739% | 406,461,000 | 415,862,000 | 276,047,000 | 233,272,000 | |
| Cost of Sales | (54,361,000) | 18.718% | (92,463,000) | (91,518,000) | (48,767,000) | (38,607,000) | |
| Gross Profit | 201,249,000 | 22.582% | 313,998,000 | 324,344,000 | 227,280,000 | 194,665,000 | |
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (9,656,000) | 168.595% | (21,972,000) | (3,185,000) | 50,000 | (2,172,000) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (6,964,000) | -52.278% | (13,943,000) | (11,711,000) | 570,000 | 0 | |
| Profit / (Loss) before Taxation | (370,339,000) | 50.296% | (1,156,344,000) | (377,555,000) | (185,843,000) | (381,543,000) | |
| Taxation | 4,124,000 | -38.795% | 34,302,000 | 6,161,000 | 2,975,000 | 778,000 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 16,027,000 | -59.665% | 64,343,000 | (2,242,000) | 879,000 | 42,000 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (350,188,000) | 75.153% | (1,057,699,000) | (373,636,000) | (181,989,000) | (380,723,000) | |
| Net Finance Costs / (Income) | 31,185,000 | 69.484% | 9,975,000 | (47,575,000) | (30,495,000) | 15,757,000 | |
| Depreciation & Amortisation | -- | -- | 112,352,000 | 51,621,000 | 37,712,000 | 28,906,000 | |
| Directors' Emoluments | -- | -- | -- | 4,478,000 | 3,841,000 | 29,325,000 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified | |
Market Valuation Indicators
| EPS (cts) | -80.000 | -- | -242.000 | -85.000 | -45.000 | -122.000 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | -- | -1.042 | -0.579 | -0.975 |
| NBV per share ($) | 7.511 | -- | 8.181 | 10.307 | 9.021 | 7.509 |
| Remarks: | Real time quote last updated: 25/09/2023 10:36 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB -350,188,000 |
| %Change | 75.153% |
| EPS / (LPS) | RMB -0.800 |
| NBV Per Share (¥) | RMB 7.511 |